These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32768658)

  • 41. Whole-cell biocatalysts by design.
    Lin B; Tao Y
    Microb Cell Fact; 2017 Jun; 16(1):106. PubMed ID: 28610636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Artificial Metalloenzymes with the Neocarzinostatin Scaffold: Toward a Biocatalyst for the Diels-Alder Reaction.
    Ghattas W; Cotchico-Alonso L; Maréchal JD; Urvoas A; Rousseau M; Mahy JP; Ricoux R
    Chembiochem; 2016 Mar; 17(5):433-40. PubMed ID: 26677011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of QM/DMD as a Multiscale Approach to Modeling Metalloenzymes.
    Gallup NM; Alexandrova AN
    Methods Enzymol; 2016; 577():319-39. PubMed ID: 27498643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Designed Metalloenzyme Achieving the Catalytic Rate of a Native Enzyme.
    Yu Y; Cui C; Liu X; Petrik ID; Wang J; Lu Y
    J Am Chem Soc; 2015 Sep; 137(36):11570-3. PubMed ID: 26318313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advancing biocatalysis through enzyme, cellular, and platform engineering.
    Cirino PC; Sun L
    Biotechnol Prog; 2008; 24(3):515-9. PubMed ID: 18335955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hybrid schemes based on quantum mechanics/molecular mechanics simulations goals to success, problems, and perspectives.
    Ferrer S; Ruiz-Pernía J; Martí S; Moliner V; Tuñón I; Bertrán J; Andrés J
    Adv Protein Chem Struct Biol; 2011; 85():81-142. PubMed ID: 21920322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Directed Evolution of Protein Catalysts.
    Zeymer C; Hilvert D
    Annu Rev Biochem; 2018 Jun; 87():131-157. PubMed ID: 29494241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Harnessing P450 Enzyme for Biotechnology and Synthetic Biology.
    Zhang L; Wang Q
    Chembiochem; 2022 Feb; 23(3):e202100439. PubMed ID: 34542923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What are the Limitations of Enzymes in Synthetic Organic Chemistry?
    Reetz MT
    Chem Rec; 2016 Dec; 16(6):2449-2459. PubMed ID: 27301318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzyme-Laden Bioactive Hydrogel for Biocatalytic Monitoring and Regulation.
    Wang X; Wang Q
    Acc Chem Res; 2021 Mar; 54(5):1274-1287. PubMed ID: 33570397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic in vivo synthetic chemistry using an artificial metalloenzyme with glycosylated human serum albumin.
    Yamada K; Muguruma K; Tanaka K
    Adv Carbohydr Chem Biochem; 2022; 82():11-34. PubMed ID: 36470648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orthogonal Expression of an Artificial Metalloenzyme for Abiotic Catalysis.
    Reynolds EW; Schwochert TD; McHenry MW; Watters JW; Brustad EM
    Chembiochem; 2017 Dec; 18(24):2380-2384. PubMed ID: 29024391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systems Biocatalysis: Development and engineering of cell-free "artificial metabolisms" for preparative multi-enzymatic synthesis.
    Fessner WD
    N Biotechnol; 2015 Dec; 32(6):658-64. PubMed ID: 25534674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A window into biocatalysis and biotransformations.
    Coward-Kelly G; Chen RR
    Biotechnol Prog; 2007; 23(1):52-4. PubMed ID: 17269670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metal-binding promiscuity in artificial metalloenzyme design.
    Pordea A
    Curr Opin Chem Biol; 2015 Apr; 25():124-32. PubMed ID: 25603469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically Encodable Scaffolds for Optimizing Enzyme Function.
    Tan YQ; Xue B; Yew WS
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in engineering proteins for biocatalysis.
    Li Y; Cirino PC
    Biotechnol Bioeng; 2014 Jul; 111(7):1273-87. PubMed ID: 24802032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artificial metalloenzymes constructed from hierarchically-assembled proteins.
    Ueno T; Tabe H; Tanaka Y
    Chem Asian J; 2013 Aug; 8(8):1646-60. PubMed ID: 23704077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design of artificial metalloproteins/metalloenzymes by tuning noncovalent interactions.
    Hirota S; Lin YW
    J Biol Inorg Chem; 2018 Jan; 23(1):7-25. PubMed ID: 29218629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.